Faculty Publications

A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM)

Simon GR, Janne PA, Langer CJ, Verschraegen CF, Dowlati A, Gadgeel SM, Kelly K, Taylor L, Obasaju CK, Kindler HL

A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM)

J Clin Oncol. 2005 Part 1 Suppl. S JUN 1;23(16):679S-679S.

Abstract

Last updated on Saturday, November 21, 2009